N2a cell

Last updated

N2a cells (also known as Neuro2a cells) are a fast-growing mouse neuroblastoma cell line. [1]

Contents

Differentiation properties

Originating from a mouse, the N2a cell line has a neuronal and amoeboid stem cell morphology, allowing it to differentiate in response to environmental factors. The differentiated cells have many properties of neurons, including neurofilaments. The differentiation of N2a cells is caused by activation of the mitogen-activated protein kinase/extracellular-signal regulated kinase (MAPK/ERK) and the phosphoinositide-3-kinase/protein kinase B (PI3K/Akt) signaling pathways. [1] The cells, due to passaging since initial collection, can exhibit responses to toxins that differ from those of neuronal cells in a live organism. [2] Synthesizing large amounts of microtubules, N2a cells are susceptible to viruses (such as herpes simplex and poliovirus) that can alter cell morphology and physiology.

Factors that Affect Differentiation of N2a Cells

Promoting Factors

  • Emodin causes N2a differentiation and growth through activation of the PI3K/Akt pathway. It does so by activating Akt while inactivating glycogen synthase kinase-3β (GSK-3β), an inhibitor of the Akt pathway. Emodin specifically causes phosphorylation of cAMP-responsive element binding protein (CREB), an important molecule in the differentiation of neurons. [3]
  • β-Hydroxy-β-methylbutyrate (HMB) causes N2a growth through activation and phosphorylation of the PI3K/Akt and MAPK/ERK signaling pathways. HMB causes activation of mTOR, which is regulated by the Atk pathway, and expression of glucose transporters in N2a cells, leading to differentiation. It also increases the activity of MEF2, mainly MEF2C, in N2a cells. [1]
  • α-lipoic acid (LA) mainly causes N2a differentiation through phosphorylation of the ERK pathway and the Akt pathway. Inhibition of only the ERK pathway will prevent LA-induced differentiation from occurring, while inhibition of the Akt pathway will not prevent LA-induced differentiation. LA causes differentiation through the production of reactive oxygen species which activate the ERK pathway. [4]

Inhibitory Factors

Research applications

N2a cells are able to rapidly, reliably, and easily differentiate, [7] making them effective for use in research applications relating to neurons and neuronal disorders. Serum withdrawal is a common method of inducing differentiation of N2a cells, involving removal of the serum that the cells are grown in to activate the signaling pathways governing differentiation. [5] N2a cells have been used to study neurite outgrowth, [1] neurotoxicity, [2] Alzheimer's disease, [8] asymmetric division of mammalian cell lines, [9] adenoviral transduction, and the diagnosing of rabies. One specific research applications is the differentiation of N2a cells into dopamine neurons for potential use in treating Parkinson's Disease.

Related Research Articles

<span class="mw-page-title-main">Brain-derived neurotrophic factor</span> Protein found in humans

Brain-derived neurotrophic factor (BDNF), or abrineurin, is a protein that, in humans, is encoded by the BDNF gene. BDNF is a member of the neurotrophin family of growth factors, which are related to the canonical nerve growth factor (NGF), a family which also includes NT-3 and NT-4/NT-5. Neurotrophic factors are found in the brain and the periphery. BDNF was first isolated from a pig brain in 1982 by Yves-Alain Barde and Hans Thoenen.

<span class="mw-page-title-main">GSK-3</span> Class of enzymes

Glycogen synthase kinase 3 (GSK-3) is a serine/threonine protein kinase that mediates the addition of phosphate molecules onto serine and threonine amino acid residues. First discovered in 1980 as a regulatory kinase for its namesake, glycogen synthase (GS), GSK-3 has since been identified as a protein kinase for over 100 different proteins in a variety of different pathways. In mammals, including humans, GSK-3 exists in two isozymes encoded by two homologous genes GSK-3α (GSK3A) and GSK-3β (GSK3B). GSK-3 has been the subject of much research since it has been implicated in a number of diseases, including type 2 diabetes, Alzheimer's disease, inflammation, cancer, addiction and bipolar disorder.

<span class="mw-page-title-main">Restriction point</span> Animal cell cycle checkpoint

The restriction point (R), also known as the Start or G1/S checkpoint, is a cell cycle checkpoint in the G1 phase of the animal cell cycle at which the cell becomes "committed" to the cell cycle, and after which extracellular signals are no longer required to stimulate proliferation. The defining biochemical feature of the restriction point is the activation of G1/S- and S-phase cyclin-CDK complexes, which in turn phosphorylate proteins that initiate DNA replication, centrosome duplication, and other early cell cycle events. It is one of three main cell cycle checkpoints, the other two being the G2-M DNA damage checkpoint and the spindle checkpoint.

<span class="mw-page-title-main">Protein kinase B</span> Set of three serine threonine-specific protein kinases

Protein kinase B (PKB), also known as Akt, is the collective name of a set of three serine/threonine-specific protein kinases that play key roles in multiple cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration.

<span class="mw-page-title-main">Nerve growth factor</span> Mammalian protein found in Homo sapiens

Nerve growth factor (NGF) is a neurotrophic factor and neuropeptide primarily involved in the regulation of growth, maintenance, proliferation, and survival of certain target neurons. It is perhaps the prototypical growth factor, in that it was one of the first to be described. Since it was first isolated by Nobel Laureates Rita Levi-Montalcini and Stanley Cohen in 1956, numerous biological processes involving NGF have been identified, two of them being the survival of pancreatic beta cells and the regulation of the immune system.

<span class="mw-page-title-main">Phosphoinositide 3-kinase</span> Class of enzymes

Phosphoinositide 3-kinases (PI3Ks), also called phosphatidylinositol 3-kinases, are a family of enzymes involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which in turn are involved in cancer.

A neurite or neuronal process refers to any projection from the cell body of a neuron. This projection can be either an axon or a dendrite. The term is frequently used when speaking of immature or developing neurons, especially of cells in culture, because it can be difficult to tell axons from dendrites before differentiation is complete.

The MAPK/ERK pathway is a chain of proteins in the cell that communicates a signal from a receptor on the surface of the cell to the DNA in the nucleus of the cell.

<span class="mw-page-title-main">Interleukin 31</span>

Interleukin-31 (IL-31) is a protein that in humans is encoded by the IL31 gene that resides on chromosome 12. IL-31 is an inflammatory cytokine that helps trigger cell-mediated immunity against pathogens. It has also been identified as a major player in a number of chronic inflammatory diseases, including atopic dermatitis.

<span class="mw-page-title-main">Midkine</span> Protein-coding gene in the species Homo sapiens

Midkine, also known as neurite growth-promoting factor 2 (NEGF2), is a protein that in humans is encoded by the MDK gene.

<span class="mw-page-title-main">GAB2</span> Protein-coding gene in the species Homo sapiens

GRB2-associated-binding protein 2 also known as GAB2 is a protein that in humans is encoded by the GAB2 gene.

The ErbB family of proteins contains four receptor tyrosine kinases, structurally related to the epidermal growth factor receptor (EGFR), its first discovered member. In humans, the family includes Her1, Her2 (ErbB2), Her3 (ErbB3), and Her4 (ErbB4). The gene symbol, ErbB, is derived from the name of a viral oncogene to which these receptors are homologous: erythroblastic leukemia viral oncogene. Insufficient ErbB signaling in humans is associated with the development of neurodegenerative diseases, such as multiple sclerosis and Alzheimer's disease, while excessive ErbB signaling is associated with the development of a wide variety of types of solid tumor.

<span class="mw-page-title-main">Insulin receptor substrate 1</span> Protein-coding gene in the species Homo sapiens

Insulin receptor substrate 1(IRS-1) is a signaling adapter protein that in humans is encoded by the IRS1 gene. It is a 131 kDa protein with amino acid sequence of 1242 residues. It contains a single pleckstrin homology (PH) domain at the N-terminus and a PTB domain ca. 40 residues downstream of this, followed by a poorly conserved C-terminus tail. Together with IRS2, IRS3 (pseudogene) and IRS4, it is homologous to the Drosophila protein chico, whose disruption extends the median lifespan of flies up to 48%. Similarly, Irs1 mutant mice experience moderate life extension and delayed age-related pathologies.

<span class="mw-page-title-main">ELK1</span> Protein-coding gene in humans

ETS Like-1 protein Elk-1 is a protein that in humans is encoded by the ELK1. Elk-1 functions as a transcription activator. It is classified as a ternary complex factor (TCF), a subclass of the ETS family, which is characterized by a common protein domain that regulates DNA binding to target sequences. Elk1 plays important roles in various contexts, including long-term memory formation, drug addiction, Alzheimer's disease, Down syndrome, breast cancer, and depression.

<span class="mw-page-title-main">RPS6KA1</span> Enzyme

Ribosomal protein S6 kinase alpha-1 is an enzyme that in humans is encoded by the RPS6KA1 gene.

Trk receptors are a family of tyrosine kinases that regulates synaptic strength and plasticity in the mammalian nervous system. Trk receptors affect neuronal survival and differentiation through several signaling cascades. However, the activation of these receptors also has significant effects on functional properties of neurons.

<span class="mw-page-title-main">RPS6KA2</span> Enzyme found in humans

Ribosomal protein S6 kinase alpha-2 is an enzyme that in humans is encoded by the RPS6KA2 gene.

The Akt signaling pathway or PI3K-Akt signaling pathway is a signal transduction pathway that promotes survival and growth in response to extracellular signals. Key proteins involved are PI3K and Akt.

Collapsin response mediator protein family or CRMP family consists of five intracellular phosphoproteins of similar molecular size and high (50–70%) amino acid sequence identity. CRMPs are predominantly expressed in the nervous system during development and play important roles in axon formation from neurites and in growth cone guidance and collapse through their interactions with microtubules. Cleaved forms of CRMPs have also been linked to neuron degeneration after trauma induced injury.

<span class="mw-page-title-main">PI3K/AKT/mTOR pathway</span> Cell cycle regulation pathway

The PI3K/AKT/mTOR pathway is an intracellular signaling pathway important in regulating the cell cycle. Therefore, it is directly related to cellular quiescence, proliferation, cancer, and longevity. PI3K activation phosphorylates and activates AKT, localizing it in the plasma membrane. AKT can have a number of downstream effects such as activating CREB, inhibiting p27, localizing FOXO in the cytoplasm, activating PtdIns-3ps, and activating mTOR which can affect transcription of p70 or 4EBP1. There are many known factors that enhance the PI3K/AKT pathway including EGF, shh, IGF-1, insulin, and CaM. Both leptin and insulin recruit PI3K signalling for metabolic regulation. The pathway is antagonized by various factors including PTEN, GSK3B, and HB9.

References

  1. 1 2 3 4 Salto, Rafael; Vílchez, Jose D.; Girón, María D.; Cabrera, Elena; Campos, Nefertiti; Manzano, Manuel; Rueda, Ricardo; López-Pedrosa, Jose M. (2015-08-12). "β-Hydroxy-β-Methylbutyrate (HMB) Promotes Neurite Outgrowth in Neuro2a Cells". PLOS ONE. 10 (8): e0135614. Bibcode:2015PLoSO..1035614S. doi: 10.1371/journal.pone.0135614 . ISSN   1932-6203. PMC   4534402 . PMID   26267903.
  2. 1 2 LePage KT, Dickey RW, Gerwick WH, Jester EL, Murray TF (2005). "On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies". Critical Reviews in Neurobiology. 17 (1): 27–50. doi:10.1615/critrevneurobiol.v17.i1.20. PMID   16307526.
  3. ↑ Park, Shin-Ji; Jin, Mei Ling; An, Hyun-Kyu; Kim, Kyoung-Sook; Ko, Min Jung; Kim, Cheol Min; Choi, Young Whan; Lee, Young-Choon (2015-02-19). "Emodin induces neurite outgrowth through PI3K/Akt/GSK-3β-mediated signaling pathways in Neuro2a cells". Neuroscience Letters. 588: 101–107. doi:10.1016/j.neulet.2015.01.001. ISSN   0304-3940.
  4. ↑ Wang, Xiaohui; Wang, Zhuyao; Yao, Yuzhen; Li, Jingjin; Zhang, Xiaojin; Li, Chuanfu; Cheng, Yunlin; Ding, Guoxian; Liu, Li; Ding, Zhengnian (2011-05-01). "Essential role of ERK activation in neurite outgrowth induced by α-lipoic acid". Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. Including the Special Section: 11th European Symposium on Calcium. 1813 (5): 827–838. doi:10.1016/j.bbamcr.2011.01.027. ISSN   0167-4889.
  5. 1 2 Evangelopoulos, Maria Elephteria; Weis, Joachim; Krüttgen, Alex (2005-05-05). "Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR". Oncogene. 24 (20): 3309–3318. doi:10.1038/sj.onc.1208494. ISSN   1476-5594. PMID   15735700.
  6. ↑ Sun, Ying-Jian; Long, Ding-Xin; Li, Wei; Hou, Wei-Yuan; Wu, Yi-Jun; Shen, Jian-Zhong (2010-02-01). "Effects of avermectins on neurite outgrowth in differentiating mouse neuroblastoma N2a cells". Toxicology Letters. 192 (2): 206–211. doi:10.1016/j.toxlet.2009.10.021. ISSN   0378-4274. PMID   19879343.
  7. ↑ Tremblay, Roger G.; Sikorska, Marianna; Sandhu, Jagdeep K.; Lanthier, Patricia; Ribecco-Lutkiewicz, Maria; Bani-Yaghoub, Mahmud (2010-01-30). "Differentiation of mouse Neuro 2A cells into dopamine neurons". Journal of Neuroscience Methods. 186 (1): 60–67. doi:10.1016/j.jneumeth.2009.11.004. ISSN   0165-0270. PMID   19903493.
  8. ↑ Provost P (2010). "Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases". Aging. 2 (3): 166–169. doi:10.18632/aging.100131. PMC   871245 . PMID   20375468.
  9. ↑ Ogrodnik M, Salmonowicz H, Brown R, Turkowska J, Sredniawa W, Pattabiraman S, Amen T, Abraham AC, Eichler N, Lyakhovetsky R, Kaganovich D (2014). "Dynamic JUNQ inclusion bodies are asymmetrically inherited in mammalian cell lines through the asymmetric partitioning of vimentin". Proceedings of the National Academy of Sciences of the United States of America . 111 (22): 8049–54. Bibcode:2014PNAS..111.8049O. doi: 10.1073/pnas.1324035111 . PMC   4050583 . PMID   24843142.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.